New research is focusing on the intricate biological processes affected by gestational diabetes, a condition impacting an increasing number of pregnancies worldwide. A study published in *Diabetes* details how the condition disrupts the way placental cells process genetic details,possibly explaining adverse outcomes for newborns [[1]]. The findings center on a crucial, yet frequently enough overlooked, step in gene expression known as pre-mRNA splicing, offering new avenues for understanding and potentially intervening in this complex pregnancy complication.
Researchers have identified disruptions in the way placental cells process genetic instructions in pregnancies complicated by gestational diabetes, a finding that could shed light on why the condition leads to adverse outcomes for newborns. The study, published in Diabetes (DOI: 10.2337/db25-0333), focuses on a process called pre-mRNA splicing within the placenta.
Gestational diabetes, which develops during pregnancy, is a growing concern globally, and understanding its underlying mechanisms is crucial for improving maternal and infant health. Pre-mRNA splicing is a vital step in gene expression, where non-coding regions are removed and coding regions are joined together to create mature messenger RNA (mRNA). This process ensures that the correct genetic information is used to make proteins.
“The molecular mechanisms underlying the numerous maternal and neonatal complications in gestational diabetes are currently poorly understood,” explained a team led by Eden Engal from the Israel-Canada Medical Research Institute at the Hebrew University of Jerusalem. The researchers discovered that this splicing process is disrupted in the placentas of individuals with gestational diabetes.
The study suggests that this dysregulation of pre-mRNA splicing may contribute to negative outcomes for the baby. While the precise consequences of these splicing errors require further investigation, the findings represent a significant step toward unraveling the complexities of gestational diabetes and potentially identifying new targets for intervention. This research could ultimately lead to improved strategies for managing the condition and minimizing risks for both mothers and their children.
To continue reading, sign up
Dear readers,
this article is only visible for logged-in users.
Please log in or register.
With free registration you benefit from the following advantages:
Get access to non-public content
